TickerFacts.

Biolife Solutions Inc (BLFS): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2014-12-31, 2015-12-31, 2018-03-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$371.89M
As of 2025-12-31
$420.00M
As of 2026-06-30
+0.7%
3-year compound annual growth
+12.7%
5-year compound annual growth
$478.05M2010-12-31: -$9.55M2011-12-31: -$11.18M2012-12-31: -$12.49M2013-12-31: -$13.27M2014-12-31: $13.94M2015-12-31: $8.51M2016-12-31: $3.17M2017-12-31: $10.09M2018-03-31: -$4.25M2018-06-30: -$12.94M2018-09-30: -$6.50M2018-12-31: $14.63M2019-03-31: -$3.74M2019-06-30: $2.07M2019-09-30: $35.19M2019-12-31: $43.45M2020-12-31: $204.43M2021-12-31: $478.05M2022-12-31: $364.19M2023-12-31: $337.66M2024-12-31: $348.91M2025-12-31: $371.89M$371.89M
2010-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$371.89M+6.6%2026-02-26, Balance as of period end
2024-12-31$348.91M+3.3%2026-02-26, Balance as of period end
2023-12-31$337.66M-7.3%2026-02-26, Balance as of period end
2022-12-31$364.19M-23.8%2025-03-03, Balance as of period end
2021-12-31$478.05M+133.8%2024-02-29, Balance as of period end
2020-12-31$204.43M+370.4%2023-03-31, Balance as of period end
2019-12-31$43.45Mn/a2022-03-31, Balance as of period end
2019-09-30$35.19Mn/a2020-05-15, Balance as of period end
2019-06-30$2.07Mn/a2020-05-15, Balance as of period end
2019-03-31-$3.74Mn/a2020-05-15, Balance as of period end
2018-12-31$14.63Mn/a2020-05-15, Balance as of period end
2018-09-30-$6.50Mn/a2020-05-15, Balance as of period end
2018-06-30-$12.94Mn/a2020-05-15, Balance as of period end
2018-03-31-$4.25Mn/c2020-05-15, Balance as of period end
2017-12-31$10.09M+218.7%2019-03-15, Balance as of period end
2016-12-31$3.17M-62.8%2017-03-15, Balance as of period end
2015-12-31$8.51Mn/c2017-03-15, Balance as of period end
2014-12-31$13.94Mn/c2016-02-25, Balance as of period end
2013-12-31-$13.27Mn/m2015-03-12, Balance as of period end
2012-12-31-$12.49Mn/m2014-02-12, Balance as of period end
2011-12-31-$11.18Mn/m2013-03-29, Balance as of period end
2010-12-31-$9.55Mn/a2012-03-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$371.89M+6.6%
Vaso Corp (VASO)2025-12-31$29.43M+6.2%
Ceribell, Inc. (CBLL)2025-12-31$155.34M-18.7%
Outset Medical, Inc. (OM)2025-12-31$126.95M+373.4%
Electromed, Inc. (ELMD)2026-06-30$53.98M+24.9%
Iridex Corp (IRIX)2026-01-03$4.92M+134.7%
Axogen, Inc. (AXGN)2025-12-31$128.85M+24.0%
Stereotaxis, Inc. (STXS)2025-12-31$13.48M+121.7%
electroCore, Inc. (ECOR)2025-12-31-$1.71Mn/m

Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗